A woman's age and the age of her eggs: why female age has such a strong impact on IVF outcomes
A reproductive specialist on why egg age, not the calendar, drives IVF results, what egg freezing actually preserves, and why no number of frozen eggs guarantees a baby.
Written by Albert Irkaliev, MD, Lead reproductologist, obstetrician-gynecologist and ultrasound diagnostics specialist

One of the working principles of reproductive medicine is that a woman's age affects the chance of IVF success mainly through the age of her oocytes, her eggs. As a woman gets older, the number of eggs available falls and the probability of errors in meiosis rises, which in turn makes aneuploid embryos more likely. But the age of the uterus and the age of the eggs are not the same thing.
A woman of 45–50 who uses donor eggs or donor embryos may still have a good chance of implantation if there are no contraindications. That does not make her own age irrelevant to the pregnancy itself: with increasing maternal age come higher risks of gestational diabetes, hypertensive disorders, pre-eclampsia, Caesarean delivery, and other obstetric complications. So it helps to keep two questions apart. The genetic potential of the embryo is tied closely to the age of the egg, while the safety of the pregnancy also depends on the woman's age and overall health.
Why eggs age
The ovarian reserve is laid down before birth. After birth, no new eggs are produced in clinically meaningful numbers. The eggs stay arrested in meiosis, and they can remain in that state for decades.
With age, the mechanisms responsible for accurate chromosome segregation become less reliable. Age-related changes in the cohesin complex and the meiotic spindle, among other mechanisms, raise the probability of meiotic errors. The result can be aneuploidy: an abnormal number of chromosomes.
One point deserves care. Popular articles often print a specific "percentage of abnormal eggs" for every maternal age, and such tables should be read with caution. Most clinical data do not come from direct genetic testing of every retrieved egg but from embryos that developed far enough to be biopsied. Franasiak and colleagues, for example, analysed 15,169 trophectoderm biopsies and showed a strong age-related rise in embryonic aneuploidy (Fertility and Sterility, 2014). It is therefore more accurate to talk about the age-related rise in the share of aneuploid embryos than to assign a universal percentage of "abnormal eggs" to each age.
How age affects IVF
Age can act on IVF at several stages. Even so, age alone cannot predict the outcome of an individual cycle with any precision: ovarian response, the number of mature eggs, fertilisation, blastocyst development, and the chromosomal status of the embryos vary considerably between patients and between laboratories.
Egg number and ovarian reserve. Ovarian reserve, and the number of eggs you can expect from one stimulation cycle, generally decline with age. Quantity and quality, though, are not the same concept. AMH and the antral follicle count (AFC) are useful mainly for predicting ovarian response and the expected egg yield. ASRM's 2021 guideline on oocyte cryopreservation states that there is insufficient evidence to recommend ovarian reserve testing as a predictor of live birth after planned egg freezing independent of age.
A useful way to put it to patients: age is the stronger predictor of whether an egg or embryo will be chromosomally normal, while ovarian reserve mainly tells us how many eggs we are likely to retrieve.
Embryo aneuploidy. As female age increases, so does the probability of producing aneuploid embryos. In the Franasiak series the risk of embryonic aneuploidy rose predictably with age, and so did the probability that a cycle would yield no euploid embryo at all. Those findings concern blastocysts that reached biopsy and should not be mechanically extrapolated to every retrieved egg.
Clinically, then, one of the most important effects of age is not that every euploid embryo from an older patient must implant less well, but that obtaining a euploid embryo becomes progressively harder with age. That distinction matters a great deal in counselling.
Egg freezing: what it actually preserves
Vitrification lets an egg keep the biological age at which it was retrieved. If an egg is collected and vitrified at 32, the woman's later ageing does not turn that egg into a "40-year-old egg". The age at retrieval is therefore one of the main predictors of its future reproductive potential, as ASRM's guideline and the two largest single-centre series (Doyle et al., 2016; Cobo et al., 2016) all show.
At the same time, egg freezing is not a guarantee of a future live birth. Not every egg survives warming, fertilises normally, grows into a blastocyst, or ends in a live birth. ASRM specifically warns of the false sense of security that arises when planned egg freezing is presented as a guarantee of future motherhood.
The best age to freeze eggs
There is no single "ideal" age that can be recommended to every woman. ASRM states that the evidence is insufficient to define a universal optimal age for planned egg freezing, although outcomes are generally better when eggs are frozen younger.
-
Before 35: on average, a more favourable balance between egg number and age-related reproductive potential.
-
35–37: freezing can still be a reasonable strategy, but counselling should address the age-related decline in efficiency.
-
38–40: meaningful reproductive potential remains, although more eggs, or more than one stimulation cycle, may be needed.
-
After 40: the procedure remains possible, but the expected efficiency with a woman's own eggs is substantially lower; individual counselling based on AMH, AFC, expected ovarian response, and reproductive goals becomes especially important.
These ranges are clinical orientation points, not guaranteed biological thresholds.
How many eggs to freeze
This is one of the most common questions, and one of the places where false precision should be avoided. ASRM currently concludes that there is insufficient evidence to recommend a universal number of mature eggs that would give a defined probability of live birth for women of a particular age.
Mathematical models and single-centre data do exist. Doyle and colleagues evaluated the age-dependent efficiency of vitrified eggs and proposed predicted live-birth probabilities by age and number of frozen eggs (Fertility and Sterility, 2016). Cobo and colleagues showed that outcomes after elective fertility preservation depend strongly on age at vitrification and on the number of eggs stored (Fertility and Sterility, 2016). These models should not be presented as a guarantee or as an official ASRM "standard".
Instead of telling a patient that "10 eggs equals a 90% chance", it is more accurate to discuss the goal of building an adequate bank of mature eggs given her age, ovarian reserve, expected response to stimulation, reproductive plans, and the performance of the particular embryology laboratory.
In general, storing more mature eggs raises the cumulative probability of obtaining an embryo suitable for transfer and, ultimately, a live birth, but the relationship is not linear and cannot guarantee the outcome for an individual patient.
Why success cannot be calculated with a simple formula
Success is sometimes estimated by simply multiplying fertilisation, blastocyst development, euploidy, and implantation rates. That is too crude for an individual prognosis.
The final outcome depends on egg maturity, survival after warming, sperm quality and the method of fertilisation, the fertilisation rate, the blastulation rate, the age-related probability of euploidy, laboratory performance, embryo-transfer factors, and maternal factors. Validated age-dependent models and a centre's own laboratory data are therefore more appropriate than a universal arithmetic formula.
Three counselling examples
A 32-year-old woman would like one child in the future. Planned egg freezing may give her a meaningful additional option. Rather than promising a specific percentage, counselling should cover her expected response to ovarian stimulation, the likely number of mature eggs per cycle, and the possibility that more than one cycle may be needed to build an adequate bank.
A 36-year-old woman would like two children. The reproductive potential needed for two children is greater than for one. A larger egg bank and the possibility of several stimulation cycles can therefore be discussed, but a clinician should not promise a predetermined number of euploid embryos.
A 40-year-old woman is considering delaying motherhood. Freezing her own eggs remains possible, but counselling should address plainly the age-related drop in efficiency, the potential need for several cycles, and the possibility that even a substantial number of retrieved eggs may not result in a live birth. The strategy should rest on an individual prognosis rather than on a target such as "60–80 eggs".
Questions patients ask
Can I still conceive naturally after freezing my eggs?
Yes. Planned egg freezing does not by itself reduce the possibility of natural conception later. Frozen eggs are an additional option; they do not become the mandatory route to pregnancy.
How long can vitrified eggs be stored?
The available evidence does not show a clinically meaningful decline in outcomes from the duration of storage alone, provided storage conditions are maintained. ASRM notes that storage time was not associated with differences in egg survival or pregnancy rates in the evidence it reviewed, and a more recent retrospective analysis of egg-donation cycles likewise found no decline in survival, fertilisation, pregnancy, or live-birth rates with longer storage (Torra-Massana et al., Reproductive BioMedicine Online, 2023), although the evidence for extremely long storage remains limited. Legal storage limits vary by jurisdiction.
Can later changes in my weight or health alter the quality of eggs that are already frozen?
Once an egg is vitrified, the woman's subsequent ageing does not change the age of that egg at retrieval. Her health at the time of a future pregnancy, however, can substantially influence obstetric risk and how safely she can carry that pregnancy.
What happens if I no longer want to use my frozen eggs?
The options depend on local legislation and on the consent documents signed with the clinic. They may include ending storage and disposal and, in some jurisdictions, donation or use in research. These questions are best discussed with the clinic in advance.
PGT: the terminology matters
PGT-A, PGT-M, and PGT-SR answer different clinical questions. PGT-A evaluates chromosome copy number and is used to identify aneuploidy in appropriate clinical settings. When a specific monogenic disorder is known in a family, PGT-M may be considered. For patients carrying a balanced structural chromosomal rearrangement, PGT-SR may be appropriate. ASRM addresses the indications and management of PGT-M for monogenic conditions in a separate committee opinion (2023).
So the presence of a hereditary disorder should not automatically be described as an "indication for PGT-A". The right form of genetic testing depends on the specific genetic risk and should be settled together with a medical geneticist. For a fuller tour of the three tests and where the field is heading, see PGT of embryos: the different types, and where the field is heading.
The age of the uterus still matters
The phrase "the age of the egg matters more than the age of the uterus" is useful for explaining the genetic side of IVF, but it should not leave the impression that a woman's age stops mattering once an embryo exists.
ACOG regards a pregnancy with delivery expected at 35 or older as carrying increased risks of adverse maternal, fetal, and neonatal outcomes (Obstetric Care Consensus No. 11, 2022). The risks of gestational diabetes, pre-eclampsia, hypertensive disorders, Caesarean delivery, and several perinatal complications rise with age, and the effect grows in the older age groups.
In other words, a younger egg can substantially reduce the age-related risk of embryonic aneuploidy, but it does not "rejuvenate" the body of the woman who will carry the pregnancy.
When to consider egg freezing
-
When motherhood is likely to be delayed substantially and keeping the option of using your own eggs matters to you.
-
Before treatment that can damage the ovaries, including certain kinds of chemotherapy and radiotherapy. ASRM's 2026 committee opinion on fertility preservation continues to recognise mature oocyte cryopreservation as an established strategy for post-pubertal patients.
-
In conditions associated with reduced ovarian reserve or a risk of accelerated loss of ovarian function, after individual assessment.
-
When you would like more than one child but expect a long interval before the later pregnancies.
Some women freeze eggs while they wait for a partner; if you would rather not wait, the single-mother-by-choice guide walks through donor conception on your own timeline.
A low AMH level on its own does not mean the eggs are of "poor quality", and it cannot predict future live birth independently of age.
Cost and the psychological side
The cost of planned egg freezing varies a great deal by country, clinic, medication needs, number of stimulation cycles, storage duration, and whether the eggs are eventually used. A blanket statement such as "freezing now is cheaper than two IVF cycles later" can therefore mislead.
An honest discussion covers not only the cost of one retrieval cycle but also the possibility of repeat stimulation, storage fees, the future ICSI, embryo culture, and embryo transfer, and the possibility that the stored eggs will never be used. The decision has psychological and ethical dimensions too; above all, clinicians should avoid creating the impression that future motherhood has been secured.
In short
The age of the egg is one of the most important factors in whether a chromosomally normal embryo can be obtained. That is why timing matters so much in reproductive medicine.
Egg freezing preserves eggs at the biological age at which they were retrieved and can therefore widen future options. It does not guarantee a live birth, and it does not remove the age-related risks of pregnancy itself. The practical messages are these:
-
The younger the age at retrieval, the higher the average future reproductive potential of those eggs.
-
AMH and AFC help predict egg quantity, but they do not replace age as the main determinant of aneuploidy risk.
-
There is no evidence-based universal number of frozen eggs that guarantees one, two, or three children.
-
PGT-A, PGT-M, and PGT-SR are not interchangeable terms.
-
Planned egg freezing should be presented as a way of widening reproductive options, not as an insurance policy with a guaranteed payout.
The most rational approach is not to hunt for a "magic number" of eggs but to build an individual strategy from age, ovarian reserve, reproductive goals, the family size you want, the expected response to stimulation, and the performance of the embryology laboratory you are working with.
This article is educational, not medical advice, and it does not replace an individual consultation. Decisions about fertility preservation, treatment protocols, and prognosis should rest on your age, medical history, ovarian reserve, the clinical situation, and the results of the fertility centre you are working with.
References
- “The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.” Franasiak JM et al., Fertil Steril 2014;101(3):656–663.e1, 1 Mar. 2014, doi.org/10.1016/j.fertnstert.2013.11.004. Accessed 5 Sept. 2026.
- “Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline.” Practice Committee of ASRM, Fertil Steril 2021;116(1):36–47, 1 July 2021, doi.org/10.1016/j.fertnstert.2021.02.024. Accessed 5 Sept. 2026.
- “Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.” Doyle JO et al., Fertil Steril 2016;105(2):459–466.e2, 1 Feb. 2016, doi.org/10.1016/j.fertnstert.2015.10.026. Accessed 5 Sept. 2026.
- “Oocyte vitrification as an efficient option for elective fertility preservation.” Cobo A et al., Fertil Steril 2016;105(3):755–764.e8, 1 Mar. 2016, doi.org/10.1016/j.fertnstert.2015.11.027. Accessed 5 Sept. 2026.
- “Long-term storage of vitrified oocytes does not affect pregnancy and live birth rates: analysis of 5362 oocyte donation cycles.” Torra-Massana M et al., Reprod Biomed Online 2023;47(3):103228, 1 Sept. 2023, doi.org/10.1016/j.rbmo.2023.04.019. Accessed 5 Sept. 2026.
- “Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11.” American College of Obstetricians and Gynecologists, Obstet Gynecol 2022;140(2):348–366, 1 Aug. 2022, doi.org/10.1097/AOG.0000000000004873. Accessed 5 Sept. 2026.
- “Indications and management of preimplantation genetic testing for monogenic conditions: a committee opinion.” Practice Committee of ASRM, Fertil Steril 2023;120(1):61–71, 1 July 2023, doi.org/10.1016/j.fertnstert.2023.03.003. Accessed 5 Sept. 2026.
- “Fertility preservation in patients with medical indications: a committee opinion (2026).” Practice Committee of ASRM, Fertil Steril 2026;125(2):247–259, 1 Feb. 2026, doi.org/10.1016/j.fertnstert.2025.12.001. Accessed 5 Sept. 2026.